Cerus is responsible for the identification, evaluation and execution of private equity and venture investments on behalf of its single-family office. Often these investments include opportunities for third party syndication, which Cerus can facilitate. The focus is always on exhaustive research and world-class execution both in sourcing and structuring investments.
Potential investments are always viewed with a clear perspective on Long Term Value Creation. Cerus is highly selective in its due diligence approach and usually completes no more than 1-3 new investments per year. Having no capital horizon limitations, Cerus can focus its resources and experience on absolute value creation. Our proprietary private equity business is primarily focused on the pharmaceutical, life sciences and healthcare industries.